NeuroBo Pharmaceuticals (NRBO) Earnings Date, Estimates & Call Transcripts → Secret energy grid to power millions of homes (From Porter & Company) (Ad) Free NRBO Stock Alerts $3.93 -0.10 (-2.48%) (As of 06/7/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends Earnings SummaryUpcoming Earnings DateAug. 14EstimatedActual EPS (May. 9) -$1.32 Missed By -$0.37 Consensus EPS (May. 9) -$0.95 Get NeuroBo Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for NRBO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNRBO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NRBO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyThe new masters of energyAccording to one source, this new grid could soon provide energy to “one billion people in the world who don’t have access to electricity right now.” And early investors could make a fortune.Click here to get all the details. NeuroBo Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.95)($0.95)($0.95)Q2 20241($1.38)($1.38)($1.38)Q3 20241($1.38)($1.38)($1.38)Q4 20241($1.38)($1.38)($1.38)FY 20244($5.09)($5.09)($5.09)NRBO Earnings Date and InformationNeuroBo Pharmaceuticals last posted its earnings results on May 9th, 2024. The reported ($1.32) EPS for the quarter, missing analysts' consensus estimates of ($0.95) by $0.37. NeuroBo Pharmaceuticals has generated $0.00 earnings per share over the last year. Earnings for NeuroBo Pharmaceuticals are expected to grow in the coming year, from ($4.89) to ($2.28) per share. NeuroBo Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.Read More NeuroBo Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/14/2024(Estimated)------- 5/9/2024Q1 2024($0.95)($1.32)($0.37)($1.32)--11/13/2023Q3 2023-($0.72)($0.72)($0.09)--8/9/2023Q2 2023-($0.16)($0.16)($0.02)--5/12/2023Q1 2023-($0.48)($0.48)($0.06)--11/14/2022Q3 2022($40.88)($28.00)+$12.88($3.50)--8/12/2022Q2 2022($40.80)($28.80)+$12.00($0.12)-- Get the Latest News and Ratings for NRBO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/13/2022Q1 2022($38.40)($26.40)+$12.00($0.11)--4/1/2022Q4 2021($36.00)($40.80)($4.80)($0.17)--11/15/2021Q3 2021($43.20)($38.40)+$4.80($0.16)--8/16/2021Q2 2021($36.00)($43.20)($7.20)($0.18)--5/17/2021Q1 2021($38.40)($36.00)+$2.40($0.15)--4/14/2021Q4 2020($45.60)($288.00)($242.40)$0.94--11/13/2020Q3 2020($40.80)($45.60)($4.80)($0.19)-- 8/11/2020Q2 2020($64.80)($35.0940)+$29.7060($0.15)--5/20/2020Q1 2020($24.00)($72.4404)($48.4404)($0.30)--8/9/2019Q2 2019-($1,200.00)($1,200.00)($5.00)-- NeuroBo Pharmaceuticals Earnings - Frequently Asked Questions When is NeuroBo Pharmaceuticals's earnings date? NeuroBo Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on NRBO's earnings history. Did NeuroBo Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, NeuroBo Pharmaceuticals (NASDAQ:NRBO) missed the analysts' consensus estimate of ($0.95) by $0.37 with a reported earnings per share (EPS) of ($1.32). Learn more on analysts' earnings estimate vs. NRBO's actual earnings. How much profit does NeuroBo Pharmaceuticals generate each year? NeuroBo Pharmaceuticals (NASDAQ:NRBO) has a recorded net income of -$12.47 million. NRBO has generated $0.00 earnings per share over the last four quarters. What is NeuroBo Pharmaceuticals's EPS forecast for next year? NeuroBo Pharmaceuticals's earnings are expected to grow from ($4.89) per share to ($2.28) per share in the next year. More Earnings Resources from MarketBeat Related Companies: MRNS Earnings HOOK Earnings IOBT Earnings SPRO Earnings ANVS Earnings EPRX Earnings CUE Earnings TPST Earnings BRNS Earnings PYRGF Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CrowdStrike's Earnings: Consolidation and AI-Driven Growth The Most Upgraded Stocks After the Q1 Earnings Season ZIM Shipping Stock Forecast, Earnings Triggers a BuyAmerican Superconductor's Earnings Surge, Future Growth ExpectedHormel: A Potential Buy Despite Post-Earnings DeclineCanopy Growth’s Earnings: Profitability Despite Industry ShiftsAbercrombie & Fitch First Quarter Earnings Surge to New Heights This page (NASDAQ:NRBO) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersSecret energy grid to power millions of homesThis high-security, secret U.S. facility has 2,100 engineers, machinists, and technicians building a new type ...Porter & Company | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroBo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.